| Supramolecular “Trojan Horse” for nuclear delivery of dual anticancer drugs Y Cai, H Shen, J Zhan, M Lin, L Dai, C Ren, Y Shi, J Liu, J Gao, Z Yang Journal of the American Chemical Society 139 (8), 2876-2879, 2017 | 279 | 2017 |
| Targeted approaches for in situ gut microbiome manipulation HL Lee, H Shen, IY Hwang, H Ling, WS Yew, YS Lee, MW Chang Genes 9 (7), 351, 2018 | 44 | 2018 |
| Enhancing poly-γ-glutamic acid production in Bacillus amyloliquefaciens by introducing the glutamate synthesis features from Corynebacterium glutamicum J Feng, Y Quan, Y Gu, F Liu, X Huang, H Shen, Y Dang, M Cao, W Gao, ... Microbial cell factories 16, 1-12, 2017 | 32 | 2017 |
| Engineered microbial systems for advanced drug delivery H Shen, N Aggarwal, KS Wun, YS Lee, IY Hwang, MW Chang Advanced Drug Delivery Reviews 187, 114364, 2022 | 28 | 2022 |
| Optimized ratiometric fluorescent probes by peptide self-assembly Y Cai, J Zhan, H Shen, D Mao, S Ji, R Liu, B Yang, D Kong, L Wang, ... Analytical chemistry 88 (1), 740-745, 2016 | 27 | 2016 |
| Engineering of a probiotic yeast for the production and secretion of medium-chain fatty acids antagonistic to an opportunistic pathogen Candida albicans H Ling, R Liu, QH Sam, H Shen, LYA Chai, MW Chang Frontiers in Bioengineering and Biotechnology 11, 1090501, 2023 | 4 | 2023 |
| Prodrug-conjugated tumor-seeking commensals for targeted cancer therapy H Shen, C Zhang, S Li, Y Liang, LT Lee, N Aggarwal, KS Wun, J Liu, ... Nature Communications 15 (1), 4343, 2024 | | 2024 |
